Abi Barrowcliff

Advanced Clinical Pharmacist in Cardiology and Meds Optimisation in Leeds, mum to Eric and Ivy, CrossFit and squash enthusiast

[Abi Barrowcliff @abi_hell]

@JonnyGabriel tirelessly campaigning for 10 years in memory of his big brother, Simon.

[Preston North End FC @pnefc]

Ten years on. This is Simon's story. 💙

#pnefc | @JonnyGabriel

[Abi Barrowcliff @abi_hell]

Well done, team! @khan_mutiba

[Professor Gerry Lee 🇺🇦 🇵🇸🇸🇸 @Gerrythecynic]

Our paper on injectables is published this week. Thanks to colleagues - @DrRaniKhatib @Angie_Durante89 @VelloneErcole @edbaker_ed Healthcare professionals’ perspectives on the use of PCSK9 inhibitors in cardiovascular disease: an in-depth qualitative study https://t.co/jpgNtPobOZ

[Abi Barrowcliff @abi_hell]

A great evening. A honour to be nominated alongside such exceptional projects. @cardiorespLTHT @CaReMeLeeds @LeedsHospitals @LTHPharmacy

[Sarah Smith @Sarah5656]

Fantastic evening at @HSJ_Awards celebrating the STF WY CVD Lipid programme. Partnership working in action! Great to connect and be inspired. @LeedsHospitals @WYpartnership @Mmfazlee @NHS_RobW @timryley1 @wesstreeting @BolaOwolabi8 @SohailBCCG @LeedsGATE @LCHNHSTrust

[Abi Barrowcliff @abi_hell]

Let's go #hsjawards @cardiorespLTHT Medicines, Pharmacy and Prescribing Initiative of the Year @WYpartnership @DrRaniKhatib

[Dr Rani Khatib FESC @DrRaniKhatib]

Please come and join our Innovative CaReMe Meds Opt team to support our Heart Failure Academy and explore other educational and research opportunities in Heart Failure.

https://t.co/8wf1TfkMg5
@LeedsHospitals
@cardiorespLTHT

[Dr Rani Khatib FESC @DrRaniKhatib]

👆 4/4
Very proud of the hard work of our Innovative CaReMe Meds Opt team at the @cardiorespLTHT. Well done to @abi_hell for her support with this paper & the delivery of this service.
We continue to innovate & improve better implementation of cardiology evidence based medicine

[Abi Barrowcliff @abi_hell]

Evidence for MRAs for HF despite ejection fraction. ⬆️ risk of hyperK ⬇️ risk of hypoK

[Abi Barrowcliff @abi_hell]

Day 3 and time for Hotline 7. Let's go #ESCCongress

[Dr Rani Khatib FESC @DrRaniKhatib]

The findings of our ACNAP survey on lipid management learning needs were eloquently presented today by our own @abi_hell. Very proud of our @cardiorespLTHT team. Very well done for conducting & presenting international research at a global level.
@LeedsHospitals
#ESCCongress

[Abi Barrowcliff @abi_hell]

How can weight loss benefit health? #ESCCongress

[Abi Barrowcliff @abi_hell]

"Development of obesity is a complex and multifactorial process". One in five adults in ESC member countries have a BMI >30 #ESCCongress

[Abi Barrowcliff @abi_hell]

Always proud to present the innovative work we do within our team and in collaboration with others. This time, I presented the findings of our survey with ACNAP on lipid management learning needs @DrRaniKhatib @lisneubeck @ACNAPPresident #ESCCongress

[Dr Rani Khatib FESC @DrRaniKhatib]

The findings of our ACNAP survey on lipid management learning needs were eloquently presented today by our own @abi_hell. Very proud of our @cardiorespLTHT team. Very well done for conducting & presenting international research at a global level.
@LeedsHospitals
#ESCCongress

[Abi Barrowcliff @abi_hell]

#ESCCongress

[Abi Barrowcliff @abi_hell]

Obicitrapid currently undergoing phase 3 trials. An oral, once daily CEPT inhibitor, that can be used in combination with high intensity statins +/- ezetimibe to reduce LDL-C

[Prof Derek Connolly @DrDerekConnolly]

The new ESC hypertension guidelines are going to increase the number of patients measuring their own blood pressure and those where therapies will be suggested

[Abi Barrowcliff @abi_hell]

New BP guidelines presented at #ESCCongress

[Dr Rani Khatib FESC @DrRaniKhatib]

What blood pressure targets to aim for according to new @escardio hypertension guidelines?
#ESCCongress 2024
@ESC_Journals @ESCardioNews

[Abi Barrowcliff @abi_hell]

More horizon scanning at #ESCCongress volanesorsen (ApoCIII) for reduction of TGs and risk of pancreatitis and olpasiran to reduce Lp(a)

[Abi Barrowcliff @abi_hell]

Biologics in dyslipidaemia. Trials underway targeting lowering Lp(a) and Apo-CIII. 2026 for CV outcomes data for inclisiran. Watch this space! #ESCCongress

[LTHPharmacyServices @LTHPharmacy]

A big congratulations to everyone involved in this interesting piece of work focused on medicines, pharmacy and prescribing!

We wish you the best of luck for the awards ceremony in November🏆

#MMPS #Pharmacy #TheLeedsWay

[Abi Barrowcliff @abi_hell]

It's been a good month for our team 🥰 Well done, everyone.

[LTHPharmacyServices @LTHPharmacy]

Congratulations to our staff in the Innovative CaReMe Medicines Optimisation Team who won best poster for 'Research & Innovation' at the @cardiorespLTHT Awards!

This is a testament to their hard work to strengthen participation and grow research and innovation, well done!

#MMPS